EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
EU-IN_VITRO_MEDICAL_DEVICES-ART_3_ANX_1
In Vitro Diagnostic Medical Devices Directive - Hazardous Substances
EU. Hazardous Substances for Purposes of Article 3 & Annex I (Essential Requirements), Directive 98/79/EC on In Vitro Diagnostic Medical Devices, 7 December 1998
This list contains a non-exhaustive inventory of hazardous substances for purposes of essential requirements (Article 3 and Annex I) for general safety, design, manufacture and hazard communication of in vitro diagnostic medical devices. It is derived from: Table 3 of Annex VI to CLP, REACH Candidate List of SVHCs, and Directive 2000/54/EC's Annex III (Biological Agents list). Note that Regulation 2017/746/EU on in vitro diagnostic medical devices was published in the EU Official Journal on 5 May 2017. With few exceptions specified in Articles 112 and 113 of this Regulation, Directive 98/79/EC is repealed, and the rules pursuant to 2017/746/EU apply, from 26 May 2022.
Last updated 11 listopada 2024. Database contains 4821 unique substances/entries.
Filter the list
|
306-004-1
|
95465-89-7
|
Press. Gas; Flam. Gas 1; Carc. 1A; Muta. 1B |
|||
|
ESACURE TZT 100
|
403-150-9
|
954-16-5
|
Acute Tox. 4; Eye Irrit. 2 |
||
|
305-975-9
|
95371-08-7
|
Carc. 1B |
|||
|
305-974-3
|
95371-07-6
|
Carc. 1B |
|||
|
305-972-2
|
95371-05-4
|
Carc. 1B |
|||
|
305-971-7
|
95371-04-3
|
Carc. 1B |
|||
|
-
|
95342-41-9
|
yes |
|||
|
-
|
953-17-3
|
Acute Tox. 3 |
|||
|
680-302-2
|
95266-40-3
|
STOT RE 2; Skin Sens. 1B |
|||
|
804-373-8
|
951659-40-8
|
Acute Tox. 4; STOT RE 2 |
|||
|
(2-BENZOTHIAZOLYLTHIO)BERNSTEINSÄURE; BTTBS; HALOX 650; IRGACOR 252
|
401-450-4
|
95154-01-1
|
Skin Sens. 1 |
||
|
C.I. REACTIVE BROWN 44
|
400-430-2
|
95078-21-0
|
Skin Sens. 1 |
||
|
A complex combination of hydrocarbons obtained by distillation of the polymerized C8 through C12 fraction from steam-cracked petroleum distillates. It consists predominantly of aromatic hydrocarbons having carbon numbers predominantly in the range of C8 through C12.
|
305-750-5
|
95009-23-7
|
Carc. 1B; Muta. 1B; Asp. Tox. 1 |
||
|
213-449-4
|
950-37-8
|
Acute Tox. 2; Acute Tox. 4 |
|||
|
213-447-3
|
950-10-7
|
Acute Tox. 1; Acute Tox. 2 |
|||
|
202-467-8
|
95-95-4
|
Acute Tox. 4; Eye Irrit. 2; Skin Irrit. 2 |
|||
|
202-464-1
|
95-92-1
|
Acute Tox. 4; Eye Irrit. 2 |
|||
|
202-461-5
|
95-87-4
|
Acute Tox. 3; Skin Corr. 1B |
|||
|
202-453-1
|
95-80-7
|
Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Skin Sens. 1 |
|||
|
202-453-1
|
95-80-7
|
Carc. 1B; Muta. 2; Repr. 2; Acute Tox. 3; Acute Tox. 4; STOT RE 2; Eye Irrit. 2; Skin Sens. 1 |
|||
|
202-453-1
|
95-80-7
|
yes |
|||
|
202-448-4
|
95-76-1
|
Acute Tox. 3; Eye Dam. 1; Skin Sens. 1 |
|||
|
202-442-1
|
95-70-5
|
Acute Tox. 3; Acute Tox. 4; Skin Sens. 1 |
|||
|
202-441-6
|
95-69-2
|
Carc. 1B; Muta. 2; Acute Tox. 3 |
|||
|
202-439-5
|
95-65-8
|
Acute Tox. 3; Skin Corr. 1B |
|||